1,101 posts by 291 firms and lawyers
Cannabis law explained by the lawyers who practise it: analysis and commentary from law firms around the world, with the Cannabis Law Journal.
After years of delays and political wrangling, the federal government’s long-awaited hearing on whether to move marijuana from Schedule I to Schedule III of the Controlled Substances Act is finally underway. On Jun. 29th, the DEA…
In a unanimous 9-0 decision, the U.S. Supreme Court held that the federal government violated the Second Amendment by prosecuting a marijuana user solely for possessing a firearm. The ruling significantly curtails the reach of 18…
On April 23rd, the DEA issued a final order moving certain marijuana classifications from Schedule I to Schedule III of the Controlled Substances Act (CSA).
Few industries in recent American history have climbed so fast or stand to fall so hard. 375 billion in annual sales by 2025. Craft breweries, alcohol veterans, and cannabis entrepreneurs bet big on a category that consumers…
On Dec. 18th, President Trump signed an executive order directing the Attorney General to expedite the rescheduling of marijuana from Schedule I to Schedule III under the Controlled Substances Act.
As reported in MJBizDaily, President Trump signed legislation on Nov. 12th, that effectively bans most consumable hemp-derived THC products nationwide. The provision was included in the spending bill that ended the historic…
This is an exciting time for cannabis entrepreneurs as the US government is poised to reclassify cannabis as a Schedule III drug in a move that recognizes cannabis’ medical and therapeutic uses and may open the door for new…
In a historic move, the DEA accepted the US Department of Health and Human Services’ recommendation to reclassify marijuana from Schedule I to a Schedule III controlled substance, arguably the most significant change to federal…
The Biden administration has proposed to reschedule marijuana from a Schedule I to Schedule III controlled substance. This reclassification will place marijuana in the same schedule as prescription drugs such as ketamine and…
Pensions are, and have been, an important compensation component for public employees, including teachers, police, fire, and other municipal positions. However, limited funds and riskier investments are threatening pension funds…
Sam Saarsteiner The German Ministry for Health has this month published a draft bill on the subject of cannabis legalisation. The draft legislation is of course a diluted version of the original ambitious plans, which faced…
1004). In an effort to promote transparency and communication with industry stakeholders, the CRA is accepting feedback on its proposed changes at this early stage in the rulemaking process.
Marijuana use has become increasingly common in the United States, with many states legalizing its use for medical or recreational purposes. S. federal law still classifies marijuana as a Schedule I drug, which means it is…
Many young industries begin with a large number of small, local entrepreneurs. Over time the more successful ones sell their operations to larger, multi-state companies that consolidate operations.
What Can I Do and Where? It is important while tackling the objective of this article to draw a distinction between legal medicinal use and legal recreational use. This article shall not cross into industrial and other uses.
S. Federal Food and Drug Administration (“FDA”) this week issued consumer warnings and sent letters to five companies, alleging that they are selling products in a way that violates Food, Drug and Cosmetic Act (the “FD&C Act”).
Cannabis cultivation and processing are rapidly-growing industries, as hemp and both recreational and medical marijuana products are being legalized across the country.
In Part 1 of this two-part series, we addressed the high-level concerns that a new investor should consider in making an investment in a state legal cannabis company.